New building set to drive translational medicine

UK Minister for Universities and Science opens the Technical Hub for bioinformatics

New building set to drive translational medicine

willetts.jpgGenome Research Limited
Professor Dame Janet Thornton, Director of EMBL-EBI, introduces UK Minister for Universities and Science, David Willetts

On Monday, 28 October, UK Minister for Universities and Science David Willetts joined key advocates of bioinformatics such as researchers, journalists, editors, and politicians to celebrate the opening of a new Technical Hub for bioinformatics on the Wellcome Trust Genome Campus.

Bioinformatics is the application of computer science to biology. This new building - and the funding that makes it possible - represents a growing awareness of the potential benefits to society that bioinformatics can bring, including better medicines, crops resistant to climatic change and the protection of biodiversity. Major support for the new build comes from the Biotechnology and Biological Sciences Research Council (BBSRC), the Medical Research Council (MRC), the Natural Environment Research Council (NERC) and the Wellcome Trust.

"This splendid new building heralds the next phase in bioinformatics at EMBL-EBI, when biodata joins the ranks of Big Data and ELIXIR pioneers a new approach to saving and sharing research data throughout Europe. These data are a goldmine for research, and are driving novel R&D in both academia and the bioindustries."

Professor Dame Janet Thornton, Director of EMBL-EBI

"This new facility is the embodiment of our investment in big data and bioinformatics. We are not only ensuring that people will receive better services and resource security, we are also maintaining UK leadership in the global science race."

David Willetts, Science and Universities Minister

As bioinformatics involves analysing very large volumes of data about living things, it is essential for tackling the serious challenges our society faces, from providing healthcare to an ageing population to securing our food and water resources. The new facilities will enable researchers throughout Europe to remain competitive in this expanding area, and will secure the UK's position at the forefront of bioinformatics.

The new building will house EMBL-EBI staff; an Industry and Translation suite, offering space for collaboration with industry partners in the spheres of pharma, agribusiness, biotech and consumer goods; and the Directorate and technical staff of the ELIXIR Technical Hub. ELIXIR is a pan European infrastructure for the sharing of biological data, funded through sustainable contributions from national member states and the European Commission.

"At the Sanger Institute, bioinformatics underpins all our research and its translation into human healthcare, and its importance will only grow further as we explore more genomes. This is indeed an important and exciting moment for European bioinformatics generally and will add greatly to the strengths of research carried out here at the Wellcome Trust Genome Campus."

Professor Sir Mike Stratton, Director of the Wellcome Trust Sanger Institute

Notes to Editors
Selected Websites
Contact the Press Office

Dr Samantha Wynne, Media Officer

Tel +44 (0)1223 492 368

Emily Mobley, Media Officer

Tel +44 (0)1223 496 851

Wellcome Sanger Institute,
Hinxton,
Cambridgeshire,
CB10 1SA,
UK

Mobile +44 (0) 7900 607793

Recent News

Low doses of radiation promote cancer-capable cells
New research in mice helps to understand the risks around exposure to low doses of radiation, such as CT scans and x-rays
Chan Zuckerberg Initiative boosts Human Cell Atlas research at the Sanger Institute
Seed Networks projects will focus on specific tissues, such as the thymus, lung, liver, kidney and immune system
Widely-available antibiotics could be used in the treatment of ‘superbug’ MRSA
Genomic analysis shows that a significant number of strains are susceptible to penicillin combined with clavulanic acid